Novo Nordisk is seeking up to $830 million in damages from KBP Biosciences, according to a ruling by a Singapore court, as the Danish drugmaker says it was misled when it bought a new hypertension ...

Hartono mengaku sakit hati setelah salah satu korban berinisial Cici tak mau lagi menjalin hubungan asmara tanpa status.

SINGAPORE, Feb. 28, 2025 /PRNewswire/ -- KBP Biosciences Pte. Ltd. (the "Company") today issued a statement addressing a recent decision by the Singapore International Commercial Court ("SICC ...

Novo Nordisk has accused Singapore-based biotech KBP Biosciences of concealing clinical data ahead of a $1.3 billion licensing agreement between the two companies in 2023 focused on blood pressure ...

Kapolres Metro KBP Heri Sulistyo Nugroho, S.I.K., M.I.K silaturahmi dengan para Dai Kamtibmas, Selasa, (11/3/2025).

CIKARANG UTARA – Polres Metro Bekasi melakukan pengecekan jalur mudik dan pos pengamanan (Pospam) sebagai bagian dari ...

Dari pemeriksaan Satreskrim Polres Cimahi, izin senjata api milik Hartono Soekwanto dikeluarkan oleh Baintelkam Polri.

Program tersebut menjadi salah satu upaya mahasiswa KKN UAD untuk meningkatkan kesadaran masing-masing individu mengenai ...

Novo Nordisk, best known for blockbuster obesity drug Wegovy, and KBP Biosciences did not immediately respond to a request for comment. Huang was not immediately available for comment. The Danish ...

Novo Nordisk filed the application after it announced on June 26, 2024 that it was stopping CLARION-CKD trial for Ocedurenone, a drug for uncontrolled hypertension and advanced chronic kidney disease ...